ATE423765T1 - Ep2-rezeptoragonisten - Google Patents

Ep2-rezeptoragonisten

Info

Publication number
ATE423765T1
ATE423765T1 AT04806216T AT04806216T ATE423765T1 AT E423765 T1 ATE423765 T1 AT E423765T1 AT 04806216 T AT04806216 T AT 04806216T AT 04806216 T AT04806216 T AT 04806216T AT E423765 T1 ATE423765 T1 AT E423765T1
Authority
AT
Austria
Prior art keywords
receptor agonists
sub
receptor
agonism
prodrug
Prior art date
Application number
AT04806216T
Other languages
German (de)
English (en)
Inventor
Richard Anthony Borman
Robert Alexander Coleman
Kenneth Lyle Clark
Keith Mills
Alexander William Oxford
Jian Zhang
Peter Thomas Duff
Original Assignee
Asterand Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterand Uk Ltd filed Critical Asterand Uk Ltd
Application granted granted Critical
Publication of ATE423765T1 publication Critical patent/ATE423765T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT04806216T 2003-12-22 2004-12-22 Ep2-rezeptoragonisten ATE423765T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0329620.9A GB0329620D0 (en) 2003-12-22 2003-12-22 EP2 receptor agonists
US53197903P 2003-12-24 2003-12-24
US62201204P 2004-10-27 2004-10-27

Publications (1)

Publication Number Publication Date
ATE423765T1 true ATE423765T1 (de) 2009-03-15

Family

ID=30776234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806216T ATE423765T1 (de) 2003-12-22 2004-12-22 Ep2-rezeptoragonisten

Country Status (8)

Country Link
US (2) US20080045596A1 (enExample)
EP (1) EP1716113B1 (enExample)
JP (1) JP2007515467A (enExample)
AT (1) ATE423765T1 (enExample)
DE (1) DE602004019697D1 (enExample)
ES (1) ES2322765T3 (enExample)
GB (1) GB0329620D0 (enExample)
WO (1) WO2005061449A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005080367A1 (en) 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
JP2009505973A (ja) 2005-08-09 2009-02-12 アステランド ユーケイ リミテッド Ｅｐ２受容体アゴニスト
JP5410271B2 (ja) * 2006-04-04 2014-02-05 アラーガン インコーポレイテッド 緑内障治療用プロスタグランジン化合物
US7491844B2 (en) * 2006-05-04 2009-02-17 Allergan, Inc. Therapeutic cyclopentane derivatives
US9365485B2 (en) 2007-01-25 2016-06-14 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US8722726B2 (en) 2007-01-25 2014-05-13 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US7781465B2 (en) * 2007-08-21 2010-08-24 Allergan, Inc. Therapeutic oxazolidinones and thiazolidinones
JP2011510965A (ja) * 2008-02-05 2011-04-07 アステランド ユーケー リミテッド 高眼圧症の治療のためのジフルオロビフェニルアミド誘導体
US8648097B2 (en) 2008-03-12 2014-02-11 Ube Industries, Ltd. Pyridylaminoacetic acid compound
WO2010108028A2 (en) 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
ES2564010T3 (es) 2009-03-30 2016-03-17 Ube Industries, Ltd. Composición farmacéutica para tratar o prevenir el glaucoma
JPWO2011030864A1 (ja) * 2009-09-11 2013-02-07 宇部興産株式会社 アニリン化合物
WO2011030872A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 スルホンアミド化合物
WO2011030873A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 ベンジル化合物
WO2011030865A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 置換ベンジル化合物
JP6289470B2 (ja) 2012-08-21 2018-03-07 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 置換ガンマラクタムの合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5576347A (en) * 1994-11-14 1996-11-19 Sredni; Benjamin Method of treating gastric ulcers
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US6090847A (en) * 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
EP1438104B1 (en) * 2001-10-26 2006-04-05 Allergan, Inc. Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
MXPA04004164A (es) * 2001-11-05 2004-09-06 Allergan Inc Analogos de omega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas del receptor ep2.

Also Published As

Publication number Publication date
EP1716113A1 (en) 2006-11-02
DE602004019697D1 (de) 2009-04-09
GB0329620D0 (en) 2004-01-28
JP2007515467A (ja) 2007-06-14
US20080045596A1 (en) 2008-02-21
US20050209336A1 (en) 2005-09-22
WO2005061449A1 (en) 2005-07-07
ES2322765T3 (es) 2009-06-26
EP1716113B1 (en) 2009-02-25

Similar Documents

Publication Publication Date Title
ATE423765T1 (de) Ep2-rezeptoragonisten
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
ATE383856T1 (de) (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim- derivative als östrogenagentien
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
ATE302775T1 (de) Carbolinderivate
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
ATE346067T1 (de) Carbolinderivate
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
BRPI0516981A (pt) inibidores de mif
ATE455103T1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
ATE308325T1 (de) Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trion derivate als metalloproteinase inhibitoren
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина
TW200724539A (en) Benzimidazole derivative and use thereof
IS8042A (is) Benz[1,2,5]thíadíazól efnasambönd
EA200300917A1 (ru) Порошковый состав
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
ATE403422T1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
RU2006107361A (ru) Средство, обладающее гематопротекторным действием
BRPI0708098B8 (pt) derivados de 4-benzoilaminofenil)-6,7-dimetóxi-2-metilaminoquinazolina, composição farmacêutica e agente antiprurítico
FR2835436B1 (fr) Instrumentation pour analgesie, notamment peridurale
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties